Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEM-KyCyDex: Weekly Carfilzomib and Dexamethasone +/- Cyclophosphamide in RRMM
NCT03336073Phase 2Unknown
- Sponsor
- Fundación PETHEMA
- Start
- Dec 2017
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in multiple myeloma (MM), sponsored by Fundación PETHEMA. Status: unknown.
02
Drugs
cyclophosphamide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03336073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03336073.